JP MORGAN/PUT/BOSTON SCIENTIFIC/74/0.1/15.11.24 | Market Closed - Börse Stuttgart 06:33:04 2024-06-14 am EDT | ||
| 0.5 EUR | +6.38% |
|
| Current month | -12.28% | ||
| 1 month | -21.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.5 | +6.38% |
| 24-06-13 | 0.47 | +2.17% |
| 24-06-12 | 0.46 | +2.22% |
| 24-06-11 | 0.45 | -6.25% |
| 24-06-10 | 0.48 | -2.04% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 06:33 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK76EP |
| ISIN | DE000JK76EP5 |
| Date issued | 2024-04-26 |
| Strike | 74 $ |
| Maturity | 2024-11-15 (152 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.74 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.04 € |
| Spread % | 7.55% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76
USD
Average target price
82.26
USD
Spread / Average Target
+7.16%
- Stock Market
- Warrants
- Warrant
